Hap Trading, LLC Agenus Inc Put Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $2,744 - $4,396	1,400 Added 10.94%	14,200 $15,000
Q2 2022 Aug 12, 2022	SELL	$1.3 - $2.64 $1,040 - $2,112	-800 Reduced 5.88%	12,800 $21,000
Q1 2022 May 12, 2022	SELL	$2.35 - $3.47 $19,270 - $28,454	-8,200 Reduced 37.61%	13,600 $17,000
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $2,044 - $4,018	-700 Reduced 3.11%	21,800 $42,000
Q3 2021 Nov 10, 2021	BUY	$4.98 - $6.63 $57,768 - $76,908	11,600 Added 106.42%	22,500 $23,000
Q2 2021 Aug 11, 2021	BUY	$2.56 - $5.49 $1,024 - $2,196	400 Added 3.81%	10,900 $11,000
Q1 2021 May 14, 2021	BUY	$2.69 - $5.25 $1,076 - $2,100	400 Added 3.96%	10,500 $25,000
Q4 2019 Feb 11, 2020	BUY	$2.41 - $4.4 $24,341 - $44,440	10,100 New	10,100 $4,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.